PJZ-31502-36665
2 vaccinations
6 coded responses
16 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 740 / OK
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
- 2020-12-17
-
2020-12-18
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue, Lactation normal, Postpartum state — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Postpartum lactating mother, so fatigue is par for the course.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-19
Survey response — days 1–6 daily, dose 1MedDRA: Flank pain — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Flank painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-20
- 2020-12-21
- 2020-12-24
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-14
Survey response — day 7, dose 2MedDRA: Flank pain — Feeling: GoodFree text: Repeated flank pain following second dose. Similar to 1st dose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — day 14, dose 2MedDRA: Myalgia — Feeling: GoodFree text: Muscle soreness- generalizedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Survey response — day 21, dose 2MedDRA: Abdominal discomfort, Nasopharyngitis — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: GI illness and subsequent head cold within 5 days of each otherMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-11
- 2021-02-20
- 2021-04-10
-
2021-07-08
Survey response — 6 months, dose 2MedDRA: Sinusitis, Upper respiratory tract infection — Feeling: GoodFree text: Upper respiratory illness/sinus infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2022-01-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Postpartum lactating mother, so fatigue is par for the course.
Systemic reaction (other): Flank pain
Release 2 — day 7, dose 2
Systemic reaction (other): Repeated flank pain following second dose. Similar to 1st dose.
Release 2 — day 14, dose 2
Symptoms: Muscle soreness- generalized
Release 3 — day 21, dose 2
Symptoms: GI illness and subsequent head cold within 5 days of each other
Release 9 — 6 months, dose 2
Symptoms: Upper respiratory illness/sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Flank pain | ✓ | ✓ | ✓ |
| SRO | Lactation normal | ○ | ✓ | ○ |
| SRO | Postpartum state | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release